| FOR IMMEDIATE RELEASE P07-01 January 5, 2007 |
Media Inquiries: |
The Food and Drug Administration (FDA) today is announcing the approval of Slentrol (dirlotapide), a prescription drug for the management of obesity in dogs. Slentrol reduces appetite and fat absorption to produce weight loss. A veterinarian will determine whether the dog should be treated, based on the dog’s weight and general health. Continue reading FDA approves first drug for obesity in dogs